Showing results (1601-1610 of 2,008) with videos related to
Sort By:
Pageof 201
Journal of Clinical Lipidology|November 23, 2019
Lipoprotein apheresis for lipoprotein(a) and cardiovascular diseasePatrick M Moriarty, Jessica V Gray, Lauryn K GorbyJournal of Clinical Lipidology|November 25, 2019
Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL studySeth J Baum, Tiziana Sampietro, Dev Datta, et al.Journal of Clinical Lipidology|December 8, 2020
Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factorsTomas Vaisar, Jennifer L Gordon, Jake Wimberger, et al.Journal of Clinical Lipidology|December 1, 2020
Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetesTeresa Buckner, Baohai Shao, Robert H Eckel, et al.Journal of Clinical Lipidology|December 8, 2018
Postprandial lipid absorption in seven heterozygous carriers of deleterious variants of MTTP in two abetalipoproteinemic familiesMathilde Di Filippo, Mathilde Varret, Vanessa Boehm, et al.Journal of Clinical Lipidology|November 10, 2021
Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome: lipoproteins in alcoholic hepatitisKaran Mathur, Eduardo Vilar-Gomez, Margery A Connelly, et al.Journal of Clinical Lipidology|January 16, 2022
Unusual late presentation of lipoprotein glomerulopathy recurrence in a Chinese kidney transplant recipientChi Yuen Cheung, Wing Hung LauJournal of Clinical Lipidology|February 16, 2021
Characteristics and trends of PCSK9 inhibitor prescription fills in the United StatesSharon Attipoe-Dorcoo, Peter Yang, Laurence Sperling, et al.Journal of Clinical Lipidology|May 6, 2014
Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?Ons Fekih, Sonia Triki, Ilhem Hellara, et al.Journal of Clinical Lipidology|May 6, 2014
Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjectsJacqueline M Anderson, Alvaro Cerda, Mario H Hirata, et al.Pageof 201